Tamoxifen therapy in breast cancer: Do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?

Simple item page
dc.contributor.authorGaibar Alonso, María
dc.contributor.authorFernández Gómez-Chacón, Gerónimospa
dc.contributor.authorRomero Lorca, Alicia
dc.contributor.authorNovillo Villajos, Apolonia
dc.contributor.authorTejerina Gómez, Armandospa
dc.contributor.authorBandrés Moya, Fernandospa
dc.contributor.authorFernández Santander, Ana
dc.date.accessioned2014-03-18T10:09:18Z
dc.date.available2014-03-18T10:09:18Z
dc.date.issued2013spa
dc.description.impact1.360 JCR (2013) Q3, 114/165 Biotechnology & applied microbiology; Q4, 167/202 Oncologyspa
dc.identifier.citationGaibar-Alonso, M., Fernández, G., Romero-Lorca, A., Novillo-Villajos, A., Tejerina-Gómez, A., Bandrés-Moya, F., & Fernández-Santander, A. (2013). Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug? The International Journal of Biological Markers, 28(4), e371-e376.spa
dc.identifier.doi10.5301/jbm.5000037spa
dc.identifier.urihttp://hdl.handle.net/11268/2180
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessen
dc.subject.unescoCáncerspa
dc.subject.unescoTratamiento médicospa
dc.titleTamoxifen therapy in breast cancer: Do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?spa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationd6fe9d38-0315-4e3c-974d-4b4a568ba81e
relation.isAuthorOfPublication6df66eed-0c97-49a7-87e4-7052fb851239
relation.isAuthorOfPublication4b02f8da-816e-471d-b72b-000a5a37e0da
relation.isAuthorOfPublication8f0ff816-e791-403f-901d-e479575cf9e8
relation.isAuthorOfPublication.latestForDiscoveryd6fe9d38-0315-4e3c-974d-4b4a568ba81e

Files

Collections

Área de Biomedicina Clásica